Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

被引：0

作者：

Luca Castagna

Alessandro Busca

Stefania Bramanti

Maria Raiola Anna

Michele Malagola

Fabio Ciceri

William Arcese

Daniele Vallisa

Francesca Patriarca

Giorgina Specchia

Roberto Raimondi

Raynier Devillier

Sabine Furst

Laura Giordano

Barbara Sarina

Jacopo Mariotti

Attilio Olivieri

Reda Bouabdallah

Carmelo Carlo-Stella

Alessandro Rambaldi

Armando Santoro

Paolo Corradini

Andrea Bacigalupo

Francesca Bonifazi

Didier Blaise

机构：

[1] Humanitas Cancer Center,Department of Clinical and Experimental Sciences, Unit of Blood Diseases and Stem Cells Transplantation, ASST Spedali Civili of Brescia

[2] BMT Unit,Hematology and BMT Unit

[3] Humanitas Research Hospital,Department of Hematology, Stem Cell Transplant Unit, Rome Transplant Network

[4] IRCCS,Hematology, Department of Medical Area

[5] Hematology Department Azienda ospedaliera Universitaria S Giovanni Battista,Hematology Section

[6] Division of Hematology and Hematopoietic Stem Cell Transplantation Unit,Hematology Department

[7] Ospedale Policlinico San Martino-IRCCS per l’Oncologia,Department of Hematology, Medical School

[8] University of Brescia,Institute of Hematology and Medical Oncology, L and A Seràgnoli, St Orsola

[9] Ospedale S Raffaele,Malpighi Hospital

[10] “Tor Vergata” University Hospital,undefined

[11] Hematology Department,undefined

[12] Ospedale Gda Saliceto di Piacenza,undefined

[13] University of Udine,undefined

[14] DAP University of Bari,undefined

[15] S. Bortolo Hospital,undefined

[16] Hematology Department,undefined

[17] Transplantation and Cellular Therapy Unit,undefined

[18] Institut Paoli-Calmettes,undefined

[19] Humanitas Cancer Center,undefined

[20] Statistical Unit,undefined

[21] Humanitas Research Hospital,undefined

[22] University of Ancona,undefined

[23] Hematology Department,undefined

[24] Lymphoma Program,undefined

[25] Institut Paoli-Calmettes,undefined

[26] Hematology and Bone Marrow Transplant Unit,undefined

[27] Azienda Ospedaliera Papa Giovanni XXIII,undefined

[28] Hematology and Bone Marrow Transplant Unit,undefined

[29] Fondazione IRCCS Istituto Nazionale Tumori and University of Milano,undefined

[30] Istituto di Ematologia,undefined

[31] Università Cattolica del Sacro Cuore,undefined

[32] Fondazione Policlinico Universitario Gemelli,undefined

[33] University of Bologna,undefined

来源：

BMC Cancer | / 20卷

关键词：

Haploidentical transplantation; Hodgkin lymphoma; Reduced intensity conditioning regimen;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] CLINICAL OUTCOMES IN HLA-IDENTICAL LIVING-RELATED DONOR RENAL TRANSPLANTS
Park, Yong Ki
Park, Chang Sue
Jeon, Jee Min
Kim, Seong Min
Oh, Hyae Ju
Sin, Yong Hun
Kim, Joong Kyung
Huh, Kil
Jeon, Gun Ung
NEPHROLOGY, 2005, 10 : A325 - A326
[22] Impact of SIRPα polymorphism on transplant outcomes in HLA-identical living donor kidney transplantation
Garcia-Sanchez, Cynthia
Casillas-Abundis, M. Aurora
Pinelli, David F.
Tambur, Anat R.
Hod-Dvorai, Reut
CLINICAL TRANSPLANTATION, 2021, 35 (09)
[23] Donor NKT cells and outcome following HLA-identical haematopoietic stem cell transplantation
Nachbaur, D.
Auberger, J.
Kircher, B.
Schumacher, P.
Clausen, J.
BONE MARROW TRANSPLANTATION, 2008, 41 : S339 - S340
[24] CLINICAL OUTCOMES OF HAPLOIDENTICAL DONOR COMPARED WITH UNRELATED AND HLA-MATCHED RELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Luo, Y.
Tan, Y.
Hu, Y.
Shi, J.
Zbeng, G.
Zheng, W.
Huang, H.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S223 - S223
[25] Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Luo, Yi
Tan, Yamin
Lai, Xiaoyu
Zheng, Weiyan
Shi, Jimin
Zheng, Gaofeng
Huang, He
BLOOD, 2012, 120 (21)
[26] T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor
A Bashey
S R Solomon
Bone Marrow Transplantation, 2014, 49 : 999 - 1008
[27] T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor
Bashey, A.
Solomon, S. R.
BONE MARROW TRANSPLANTATION, 2014, 49 (08) : 999 - 1008
[28] Haploidentical Donor Transplantation Is Not Inferior to Identical Sibling Donor for Patients with Chronic Myeloid Leukemia in Blast Crisis
Ma, Yanru
Xu, Lanping
Huang, Xiaojun
BLOOD, 2015, 126 (23)
[29] Donor Selection for Allogeneic Stem Cell Transplantation In Elderly Patients with Advanced MDS: Younger Matched-Unrelated Donor or HLA-Identical Sibling ?
Kroger, Nicolaus
Zabelina, Tatjana
van Biezen, Anja
Zander, Axel R.
de Witte, Theo
BLOOD, 2010, 116 (21) : 402 - 403
[30] Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
Hamaki, T
Kami, M
Kim, SW
Onishi, Y
Kishi, Y
Murashige, N
Hori, A
Kojima, R
Sakiyama, M
Imataki, O
Heike, Y
Tanosaki, R
Masuo, S
Miyakoshi, S
Taniguchi, S
Tobinai, K
Takaue, Y
BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 891 - 900

← 1 2 3 4 5 →